Back
Matthews Emerging Markets Eq Actv ETF Vs. PTC Therapeutics Industry Stock Comparison
Buy
53
MEM
Matthews Emerging Markets Eq Actv ETF
Last Price:
32.12
Seasonality Move:
3.75%
Sell
47
PTCT
PTC Therapeutics
Last Price:
49.63
Seasonality Move:
17.12%
Buy
53
Matthews Emerging Markets Eq Actv ETF (MEM)
is a Buy
Is Matthews Emerging Markets Eq Actv ETF a Buy, Sell or Hold?
- The current Matthews Emerging Markets Eq Actv ETF [MEM] share price is $32.03. The Score for MEM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- MEM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $50.29. The Score for PTCT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MEM Stock Price Chart
What is Matthews Emerging Markets Eq Actv ETF's stock price today?
-
The Matthews Emerging Markets Eq Actv ETF share price today is $32.03
The current trend is relatively stagnant and MEM is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $50.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.
MEM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 48.07 | Sell |
| Chaikin Money Flow: | 2010 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.64 - 32.66) | Sell |
| Bollinger Bands (100): | (30.1 - 32.98) | Buy |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.11 | Buy |
| Relative Strength Index (14 RSI): | 66.75 | Buy |
| Chaikin Money Flow: | -849912 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.04 - 46.16) | Buy |
| Bollinger Bands (100): | (32.47 - 41.53) | Buy |
MEM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.86 | Buy |
| 20-day SMA: | 32.03 | Sell |
| 50-day SMA: | 32.77 | Sell |
| 200-day SMA: | 30.62 | Buy |
| 8-day EMA: | 31.88 | Buy |
| 20-day EMA: | 32.04 | Sell |
| 50-day EMA: | 32.13 | Sell |
| 200-day EMA: | 30.72 | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.81 | Buy |
| 20-day SMA: | 43.67 | Buy |
| 50-day SMA: | 40.62 | Buy |
| 200-day SMA: | 34.19 | Buy |
| 8-day EMA: | 46.55 | Buy |
| 20-day EMA: | 44.07 | Buy |
| 50-day EMA: | 41.1 | Buy |
| 200-day EMA: | 35.83 | Buy |
Matthews Emerging Markets Eq Actv ETF Earnings Growth & MEM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.82 per share.
Matthews Emerging Markets Eq Actv ETF Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||